Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
1999-10-19
2002-06-25
Jastrzab, Jeffrey R. (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S063000, C125S901000
Reexamination Certificate
active
06411844
ABSTRACT:
FIELD OF THE INVENTION
This invention pertains to an implantable medical device, and more particularly, to an implantable cardioverter-defibrillator (ICD), which senses a dangerous cardiac arrhythmia and, in response, provides therapy to a patient's heart to revert it to a normal sinus rhythm. More particularly, this invention pertains to an ICD in which a depolarization pulse is applied after a defibrillation shock, and/or the electrodes used to deliver the defibrillation shock are shorted together for a brief time period, to discharge any residual charges, thereby insuring that intrinsic cardiac signals indicative of fibrillation are not masked.
BACKGROUND OF THE INVENTION
As used herein, the term “arrhythmia” refers to any abnormal heart rhythm that may be dangerous to the patient and specifically includes fibrillation, atrial tachycardias, supraventricular tachycardias (SVT), ventricular tachycardias (VT), ventricular fibrillation and flutter (VF). As further used-herein, the term “therapy” refers to any means used by the ICD device to restore normal heart rhythm, such as defibrillation, cardioversion, and antitachycardia pacing. The term “cardioverter” refers to a device capable of providing defibrillation therapy, cardioversion therapy, or both.
Typically, defibrillation therapy consists of the application to cardiac tissue of one or more electrical shocks of considerable amplitude and duration. In cases where a first defibrillation shock is not successful, a second shock having much smaller amplitude applied within about 1-2 seconds after the first shock may suffice to revert the heart to normal sinus rhythm. It is desirable to apply a subsequent defibrillation shock as soon as it is discovered that the heart has not reverted despite earlier attempts.
However, such therapy immediately after the delivery of a defibrillation shock has not always been possible because it may not be possible to sense the on-going arrhythmia (including VF) for many seconds after a defibrillation shock is applied. More particularly, until now such early therapy additional (e.g., second-shock) could not be applied because the first defibrillation shock results in a build-up of residual charge on the electrodes and a local polarization of the tissues which would dissipate only after about 10 seconds. This may mask any low amplitude VF, and necessarily lead to a delay in the application of another shock.
SUMMARY OF THE INVENTION
In its broadest sense, the present invention pertains to an ICD wherein a two-step process is executed after the administration of high energy level therapy such as a defibrillation shock consisting of one or more high amplitude pulses. The process consists of first applying a relatively short duration and low amplitude pulse, preferably having a polarity opposite to that of the last pulse of the therapy, to depolarize the electrodes thereby dissipating any residual or parasitic charges therein. Following this short duration pulse, the electrodes used to apply the therapy are momentarily shorted together to discharge any remaining residual charges.
In a particularly advantageous arrangement, a multiphasic shock is generated by a circuit that includes a capacitor charged to a preselected voltage of at least 100V and then discharged through a set of electronic switches arranged in a bridge-like fashion. In this arrangement, the short duration pulse is generated by applying a charge from the capacitor to the electrodes using the same switches that control or steer the therapy shock. After the short duration pulse, additional switches are used to short the electrodes together.
Advantageously, the electrodes may also be shorted to the conductive case of the ICD, especially in arrangements where the conductive case acts as anelectrode as well.
REFERENCES:
patent: 4406286 (1983-09-01), Stein
patent: 4543956 (1985-10-01), Herscovici
patent: 4637397 (1987-01-01), Jones et al.
patent: 4809697 (1989-03-01), Causey, III et al.
patent: 4903700 (1990-02-01), Whigham et al.
patent: 4944299 (1990-07-01), Silvian
patent: 5257621 (1993-11-01), Bary et al.
patent: 5330512 (1994-07-01), Hauck et al.
patent: 5507781 (1996-04-01), Kroll et al.
patent: 5522853 (1996-06-01), Kroll
patent: 5601608 (1997-02-01), Mouchawar
patent: 5741312 (1998-04-01), Vonk et al.
patent: 5913877 (1999-06-01), Kroll et al.
patent: 5964787 (1999-10-01), Kerver et al.
patent: 6002962 (1999-12-01), Huang et al.
patent: 6067472 (2000-05-01), Vonk et al.
Chang Steve
Kroll Mark W
Jastrzab Jeffrey R.
Pacesetter Inc.
LandOfFree
Fast recovery sensor amplifier circuit for implantable... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fast recovery sensor amplifier circuit for implantable..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fast recovery sensor amplifier circuit for implantable... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2925008